Early lung cancer detection with a machine learning model based on imaging, clinical, and DNA methylation biomarkers Aug 15, 2023
MaxCyte signs strategic platform license with prime medicine to advance next-generation gene editing therapies for patients Aug 10, 2023
NCI funds study to investigate the underlying cellular mechanisms that drive ER+ breast cancer Aug 7, 2023